CN111825776A - 一种卤化海藻多糖的制备工艺及应用 - Google Patents
一种卤化海藻多糖的制备工艺及应用 Download PDFInfo
- Publication number
- CN111825776A CN111825776A CN202010524126.4A CN202010524126A CN111825776A CN 111825776 A CN111825776 A CN 111825776A CN 202010524126 A CN202010524126 A CN 202010524126A CN 111825776 A CN111825776 A CN 111825776A
- Authority
- CN
- China
- Prior art keywords
- halogenated
- algal polysaccharide
- algal
- polysaccharide
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 74
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title abstract description 24
- 150000004676 glycans Chemical class 0.000 title abstract 9
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 20
- 150000002367 halogens Chemical class 0.000 claims abstract description 20
- 241000700605 Viruses Species 0.000 claims abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
- 201000010099 disease Diseases 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 4
- 239000000645 desinfectant Substances 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 3
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims abstract description 3
- 150000004804 polysaccharides Chemical class 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 239000011630 iodine Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 229920000615 alginic acid Polymers 0.000 claims description 5
- -1 benzozers Polymers 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 150000004781 alginic acids Chemical class 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 230000002924 anti-infective effect Effects 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 238000010668 complexation reaction Methods 0.000 claims description 2
- ORXJMBXYSGGCHG-UHFFFAOYSA-N dimethyl 2-methoxypropanedioate Chemical compound COC(=O)C(OC)C(=O)OC ORXJMBXYSGGCHG-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 241000252230 Ctenopharyngodon idella Species 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229920001277 pectin Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 10
- 241001465754 Metazoa Species 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 229920002521 macromolecule Polymers 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 5
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000238553 Litopenaeus vannamei Species 0.000 description 3
- 206010027982 Morphoea Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- MGFWQHJISKJHMB-UHFFFAOYSA-N 1-iodopropane-1,2,3-triol Chemical compound OCC(O)C(O)I MGFWQHJISKJHMB-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 241000252228 Ctenopharyngodon Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000196252 Ulva Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Inorganic materials Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920003175 pectinic acid Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001180 sulfating effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G13/00—Protecting plants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
- A01K61/13—Prevention or treatment of fish diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Environmental Sciences (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Marine Sciences & Fisheries (AREA)
- Diabetes (AREA)
- Animal Husbandry (AREA)
- Toxicology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
本发明公开了一种卤化海藻多糖的制备工艺及应用，属于大分子有机物及其制备工艺领域。本发明卤化海藻多糖以卤素分子为配位中心，与海藻多糖的羟基或羧基形成配位键，其制备工艺包括：（1）海藻多糖与卤素分子的络合反应；（2）卤化海藻多糖的稳定化处理。本发明卤化海藻多糖是一种大分子络合物，提高络合物稳定性的同时，其抑菌与消毒活性也得到了提高，而且海藻多糖作为一种天然的大分子化合物也为动植物提供了海洋生物活性营养物质，应用更加安全高效；本发明技术填补了卤化海藻多糖制备技术的空白，可广泛应用于作物病毒病害的防治，水产品消毒和抗感染领域，具有广阔的应用前景。
Description
技术领域
本发明涉及一种卤化海藻多糖的制备工艺及应用，具体涉及一种以卤素分子为配位中心，与海藻多糖的羟基或羧基配位形成大分子络合物的制备工艺及其在作物病毒、水产品养殖消毒和抗感染领域的应用，属于大分子有机物及其制备工艺领域。
背景技术
卤素可以氧化菌体中的活性基团，与氨基结合使蛋白质变性，所以具有显著的杀菌性能。如氟化钠对真菌及芽胞有强大的杀菌力，1-2%的碘酊常用作皮肤消毒，碘甘油常用于粘膜的消毒。常见的含卤素的杀菌消毒剂有漂白粉、碘酊、氯胺等。但是卤素类杀菌消毒产品的稳定性较差，易受温度、光照、蒸发等条件影响而失效，而且其消毒力受污物的影响大，需要在强酸下才有效，碱性条件下效果降低。
海藻多糖跟陆生植物中的多糖成分相比，具有特殊的海洋硫酸化结构，具有抑制病毒的作用。研究表明，海藻多糖抑制病毒作用主要通过干扰病毒与宿主细胞的粘附作用，抑制其逆转录酶活性达成。病毒感染宿主细胞主要通过识别细胞表面的糖蛋白，结合锚定之后进入细胞内部，然后进行逆转录、复制等过程。由于宿主细胞糖蛋白主要带负电荷，因此海藻多糖可以模拟宿主细胞糖蛋白，与病毒结合，从而阻断病毒感染细胞。且海藻多糖原料来源丰富，生产成本低，制备工艺简单，属于绿色环保产品。
现有专利CN 106496347 A中公开了一种海藻多糖铜络合物的制备方法，通过海藻提取多糖，再于中性条件下与铜离子通过共热法制备海藻多糖铜络合物，它可用作饲料添加剂、功能性生物肥料或植物杀菌剂；专利201510929052.1公开了一种含碘多糖，该发明中的高取代含碘多糖相对于含碘小分子，其突出优点是含碘小分子被高分子化后，细胞毒性大大降低，而且不存在由扩散导致的小分子泄露问题。分析现有技术，为发现通过卤化海藻多糖提高产品抑菌抗病效果的技术报道，为弥补现有技术的不足，本发明提供了一种新型的卤化海藻多糖，是一种大分子络合物，提高稳定性的同时，抑菌与消毒活性也得到了提高，而海藻多糖作为一种天然的大分子化合物也为动植物提供了海洋生物活性营养成分，应用更加安全高效。
发明内容
针对现有技术的不足，本发明的目的在于提供一种新型的卤化海藻多糖及其制备工艺，所述卤化海藻多糖稳定性高，安全环保，有效成分活性强；本发明专利技术填补了卤化海藻多糖制备技术的空白，可广泛应用于作物病毒病害的防治，水产品消毒和抗感染领域。
为实现上述目的，本发明采用如下技术方案：
本发明提供一种卤化海藻多糖制备工艺及应用，该卤化海藻多糖是以卤素分子为配位中心，与海藻多糖的羟基或羧基配位形成的大分子络合物。其化学通式为：
（C6H10O5）n·X2
其中n代表自然整数，X代表氯、溴、碘等卤素原子。
一种卤化海藻多糖的制备工艺，具体如下：
（1）海藻多糖与卤素分子的络合反应：在溶剂中溶解海藻多糖使其浓度达到2~30%，再加入卤素分子，在20~50℃的条件下密封搅拌反应2~4小时。
（2）卤化海藻多糖的稳定化处理：向络合反应液中添加一定量的表面活性剂或增稠剂辅料，以增加产物的稳定性与溶解性。
本发明所述一种卤化海藻多糖制备工艺，其特征在于，海藻多糖来源于海洋藻类，经提取、分离制备而成，是一种天然大分子，包括海藻淀粉、褐藻胶、卡拉胶、琼胶、岩藻聚糖、鼠李聚糖、木聚糖、甘露聚糖以及海藻中含有的各类杂多糖。
本发明所述一种卤化海藻多糖制备工艺，其特征在于，溶剂为水、乙醇、二甲亚砜、二甲基甲酰胺中的一种或几种。
本发明所述一种卤化海藻多糖制备工艺，其特征在于，卤素为氯、溴、碘中的一种。
本发明所述一种卤化海藻多糖制备工艺，其特征在于，表面活性剂为司盘类、吐温类、苄泽类、普朗尼克类中的一种。
本发明所述一种卤化海藻多糖制备工艺，其特征在于，增稠剂为淀粉类、纤维素类、果胶类、海藻酸类中的一种。
本发明所述的卤化海藻多糖可用于防治病毒性病害，如对虾白斑综合症、桃拉病毒、草鱼出血病以及人类消化道病等。
本发明的有益效果是：（1）本发明的卤化海藻多糖是一种以卤素分子为配位中心的络合物，具有更好的稳定性，有利于卤化海藻多糖功能活性的发挥；（2）海藻多糖藻长期使用不会对动植物产生伤害作用，而且海藻多糖作为配合物与卤素分子结合，为动植物提供了营养成分，更加安全环保；（3）海藻多糖具有一定抑菌、抗病毒活性，可以与卤素形成协同效应，提高活性，增加了海藻多糖的应用途径；（4）海藻多糖具有明显的抗病毒作用和免疫增强作用，对多种病毒具有治疗效果，可以用于作物病毒病的防治、水产消毒剂和抗感染药品等是一种新型的抗菌抑菌生物制剂；（5）本发明卤化海藻多糖的制备方法简单，成本低廉，适合工业规模上大批量生产，具有广阔的应用前景。
具体实施方式
以下结合具体实施例,对本发明进行进一步详细说明。
实施例1 碘化绿藻多糖的制备
取绿藻浒苔中水溶性多糖10g，加水溶解成10%的水溶液。取1.2g碘先溶于5mL KI溶液中，再慢慢滴加至多糖溶液中，封口，40℃下水浴搅拌反应2小时，得到碘化绿藻多糖溶液。再向反应液中添加适量吐温60和海藻酸，继续搅拌30min，即为碘化绿藻多糖，含有机碘1.2%；
实施例2 溴化海藻酸钠的制备
取海藻酸钠5g，加水配制成2%的水溶液，边搅拌边向其中缓慢滴加4mL溴水，封口，50℃下水浴搅拌反应3.5小时。再向反应液中添加适量甘油和明胶，继续搅拌30min，即为溴化海藻酸钠。
实施例4 碘化绿藻多糖在对虾白斑病中的应用
实施例1制备的碘化绿藻多糖应用于南美白对虾白斑病的防治中。试验区的南美白对虾养殖面积12亩，每口6亩，池深1.5m。2019年7月初发病时，对虾平均体长已达7.63cm。向饲料中拌料3g碘化绿藻多糖，连续投喂3天后，白斑病得到了有效控制，此后继续使用一周，正常投食饵料，再未出现病害爆发，南美白对虾长至12.11cm，成活率75％以上。说明本发明卤化海藻多糖对病毒具有治疗效果，并可促进生物成长。
以上实施例仅用于说明本发明的技术方案，而非对其进行限制；尽管参照前述实施例对被发明进行了详细的说明，但对于本领域的普通技术人员来说，依然可以对前述实施例所记载的技术方案进行修改，或者对其中部分技术特征进行等同替换；而对这些修改或者替换，并不使相应技术方案的本质脱离本发明所要求保护的技术方案的精神和范围。
Claims (9)
1.一种卤化海藻多糖，其特征在于其化学通式为：
（C6H10O5）n·X2
其中n代表自然整数，X代表卤素原子。
2.根据权利要求1所述一种卤化海藻多糖，其特征在于，所述卤化海藻多糖以卤素分子为配位中心，与海藻多糖的羟基或羧基通过配位键形成的一种大分子络合物。
3.根据权利要求1所述一种卤化海藻多糖，其特征在于所述卤化海藻多糖的制备工艺包括：
（1）海藻多糖与卤素分子的络合反应：在溶剂中溶解海藻多糖使其浓度达到2~30%，再加入卤素分子，在20~50℃的条件下密封搅拌反应2~4小时；
（2）卤化海藻多糖的稳定化处理：向络合反应液中添加一定量的表面活性剂或增稠剂辅料，以增加产物的稳定性与溶解性。
4.根据权利要求3所述一种卤化海藻多糖制备工艺，其特征在于所述步骤（1）中的溶剂为水、乙醇、二甲亚砜、二甲基甲酰胺中的一种或几种。
5.根据权利要求3所述一种卤化海藻多糖制备工艺，其特征在于所述卤素为氯、溴、碘中的一种。
6.根据权利要求3所述一种卤化海藻多糖制备工艺，其特征在于所述表面活性剂为司盘类、吐温类、苄泽类、普朗尼克类中的一种。
7.根据权利要求3所述一种卤化海藻多糖制备工艺，其特征在于所述增稠剂为淀粉类、纤维素类、果胶类、海藻酸类中的一种。
8.根据权利要求1所述一种卤化海藻多糖，其特征在于所述卤化海藻多糖用于作物病毒病的防治、水产消毒剂和抗感染药品。
9.根据权利要求8所述的一种卤化海藻多糖，其特征在于所述作物病毒病包括对虾白斑综合症、桃拉病毒、草鱼出血病以及人类消化道病。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010524126.4A CN111825776A (zh) | 2020-06-10 | 2020-06-10 | 一种卤化海藻多糖的制备工艺及应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010524126.4A CN111825776A (zh) | 2020-06-10 | 2020-06-10 | 一种卤化海藻多糖的制备工艺及应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111825776A true CN111825776A (zh) | 2020-10-27 |
Family
ID=72899314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010524126.4A Pending CN111825776A (zh) | 2020-06-10 | 2020-06-10 | 一种卤化海藻多糖的制备工艺及应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111825776A (zh) |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH367814A (fr) * | 1958-04-22 | 1963-03-15 | Fo We Forschungs Und Verwertun | Procédé pour l'obtention de dérivés halogénés d'esters sulfuriques de polysaccharides |
| JPH0427388A (ja) * | 1990-05-23 | 1992-01-30 | Kanebo Ltd | 修飾プロテアーゼ及びその製造法 |
| CN1318539A (zh) * | 2001-04-28 | 2001-10-24 | 曾雄飞 | 氨基酸碘络合物 |
| WO2001078751A1 (en) * | 2000-04-17 | 2001-10-25 | 'armenicum+' Jsc | Antiviral and antibacterial pharmaceutical preparation 'armenicum' and its use for treatment of infectious diseases |
| CN1834087A (zh) * | 2005-03-17 | 2006-09-20 | 曾雄飞 | 有机碘络合物 |
| CN101371852A (zh) * | 2008-09-26 | 2009-02-25 | 广西壮族自治区兽医研究所 | 一种防治对虾白斑病的方法 |
| CN101999517A (zh) * | 2010-10-28 | 2011-04-06 | 北京资源亚太饲料科技有限公司 | 低分子海藻多糖微量元素螯合物的制备方法及应用 |
| CN103304304A (zh) * | 2012-03-13 | 2013-09-18 | 中国海洋大学生物工程开发有限公司 | 一种碘化壳寡糖海藻生物肥料的制备方法 |
| CN103933062A (zh) * | 2014-03-12 | 2014-07-23 | 贵州扬生医用器材有限公司 | 聚氨基多糖多肽络合碘复合体系溶液及其制法 |
| CN104610568A (zh) * | 2014-12-02 | 2015-05-13 | 天津禹王生物医药科技有限公司 | 碘化壳聚糖海绵敷料的制备方法 |
| CN105348410A (zh) * | 2015-12-14 | 2016-02-24 | 中山大学 | 一种含碘多糖及其合成方法和应用 |
| US20160280804A1 (en) * | 2015-03-25 | 2016-09-29 | Mannington Mills, Inc. | Halogenated Polysaccharides |
| CN107417807A (zh) * | 2017-08-15 | 2017-12-01 | 浦江县昂宝生物技术有限公司 | 一种海藻多糖的提取方法 |
-
2020
- 2020-06-10 CN CN202010524126.4A patent/CN111825776A/zh active Pending
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH367814A (fr) * | 1958-04-22 | 1963-03-15 | Fo We Forschungs Und Verwertun | Procédé pour l'obtention de dérivés halogénés d'esters sulfuriques de polysaccharides |
| JPH0427388A (ja) * | 1990-05-23 | 1992-01-30 | Kanebo Ltd | 修飾プロテアーゼ及びその製造法 |
| WO2001078751A1 (en) * | 2000-04-17 | 2001-10-25 | 'armenicum+' Jsc | Antiviral and antibacterial pharmaceutical preparation 'armenicum' and its use for treatment of infectious diseases |
| CN1318539A (zh) * | 2001-04-28 | 2001-10-24 | 曾雄飞 | 氨基酸碘络合物 |
| CN1834087A (zh) * | 2005-03-17 | 2006-09-20 | 曾雄飞 | 有机碘络合物 |
| CN101371852A (zh) * | 2008-09-26 | 2009-02-25 | 广西壮族自治区兽医研究所 | 一种防治对虾白斑病的方法 |
| CN101999517A (zh) * | 2010-10-28 | 2011-04-06 | 北京资源亚太饲料科技有限公司 | 低分子海藻多糖微量元素螯合物的制备方法及应用 |
| CN103304304A (zh) * | 2012-03-13 | 2013-09-18 | 中国海洋大学生物工程开发有限公司 | 一种碘化壳寡糖海藻生物肥料的制备方法 |
| CN103933062A (zh) * | 2014-03-12 | 2014-07-23 | 贵州扬生医用器材有限公司 | 聚氨基多糖多肽络合碘复合体系溶液及其制法 |
| CN104610568A (zh) * | 2014-12-02 | 2015-05-13 | 天津禹王生物医药科技有限公司 | 碘化壳聚糖海绵敷料的制备方法 |
| US20160280804A1 (en) * | 2015-03-25 | 2016-09-29 | Mannington Mills, Inc. | Halogenated Polysaccharides |
| CN105348410A (zh) * | 2015-12-14 | 2016-02-24 | 中山大学 | 一种含碘多糖及其合成方法和应用 |
| CN107417807A (zh) * | 2017-08-15 | 2017-12-01 | 浦江县昂宝生物技术有限公司 | 一种海藻多糖的提取方法 |
Non-Patent Citations (6)
| Title |
|---|
| 中国兽药典委员会编: "《兽药使用指南.化学药品卷：中华人民共和国兽药典兽药使用指南 2005年版》", 30 April 2006, 中国农业出版社 * |
| 何培民 等: "对虾白斑综合征病毒免疫防治研究进展", 《海洋渔业》 * |
| 王文静 等: "《化工生产技术》", 28 February 2017, 中国海洋大学出版社 * |
| 闫焕新 等: "海藻酸-碘复合物的制备", 《食品与药品》 * |
| 雷爱莹 等: "复合海藻多糖对凡纳滨对虾生长和抗病力影响的试验报告", 《广西畜牧兽医》 * |
| 黄玉媛 等: "《精细化工配方常用原料手册》", 31 March 1998, 广东科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1209986B1 (en) | Metal-containing compositions, preparations and uses | |
| CN107902736B (zh) | 复合絮凝抑藻剂的制备方法及复合絮凝抑藻剂 | |
| CN106496347A (zh) | 一种海藻多糖铜络合物的制备方法 | |
| CN110624012A (zh) | 一种保护猪胃肠的纳米聚维酮碘口服液及其制备方法 | |
| CN102405935B (zh) | 鱼精蛋白复配制剂及其制备方法和应用 | |
| US20030171598A1 (en) | Aminoacid-iodine complex | |
| CN105557751A (zh) | 高分子生物有机碘及其制备方法、水产养殖疾病防治方法 | |
| CN111825776A (zh) | 一种卤化海藻多糖的制备工艺及应用 | |
| CN106386867A (zh) | 含几丁聚糖和淡紫拟青霉的农药组合物、制备方法和应用 | |
| CN105418799A (zh) | 一种壳寡糖碘络合物及其制备方法和应用 | |
| CN108451903B (zh) | 一种聚维酮碘溶液及其制备方法 | |
| CN107459582A (zh) | 一种具有杀菌作用的多糖硒铜的制备方法 | |
| CN101269164B (zh) | 用于家畜、家禽及水产动物的病毒菌血清芦荟疫苗粉剂及口服液的制备方法 | |
| KR101053186B1 (ko) | 다유화 용액의 제조방법, 및 이를 이용한 침강유황의 제조방법 | |
| CN104884066B (zh) | 含有壳寡糖的淀粉酶活性抑制用组合物 | |
| Panchal et al. | Chitosan as a natural polymer: an overview | |
| CN102218079A (zh) | 护创用生物胶体分散剂及其制备方法 | |
| RU2189155C2 (ru) | Способ обогащения чеснока и корнеплодов селеном | |
| CN111771905A (zh) | 一种固态过氧化氢及其制备方法和应用 | |
| CN117229429B (zh) | 一种壳寡糖硫酸盐及其制备方法 | |
| CN102846489A (zh) | 一种盐酸聚六亚甲基胍碘药浴液及其制备方法 | |
| CN112675191B (zh) | 一种兽用聚维酮碘溶液及其制备方法 | |
| CN101974038B (zh) | 寡聚氨基糖酸及其制备方法 | |
| JPH09151104A (ja) | 抗菌持続性を有する殺菌水 | |
| CN108992448B (zh) | 一种观赏鱼用含盐除菌片剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 266000 No. 127 Huizhiqiao Road, Qingdao High-tech Zone, Shandong Province Applicant after: Qingdao Haida biological Group Co.,Ltd. Address before: 266000 No. 127 Huizhiqiao Road, Qingdao High-tech Zone, Shandong Province Applicant before: QINGDAO SEAWIN BIOTECH GROUP Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201027 |
|
| RJ01 | Rejection of invention patent application after publication |